Wnt Signaling
-
Protecting the injured kidney
Leslie Gewin and colleagues have upended conventional dogma about Wnt/beta-catenin signaling in the kidney, finding that it protects against chronic kidney disease rather than promoting it. Read MoreJun 4, 2020
-
Clues to lung injury in preterm babies
Jennifer Sucre and colleagues have discovered a factor that contributes to the pathological changes of bronchopulmonary dysplasia, the most common complication of preterm birth. Read MoreMar 5, 2020
-
A “rheostat” for cancer signals
Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells. Read MoreAug 27, 2019
-
Lung diseases share molecular signature
Lung diseases of infancy and aging share a molecular signature, pointing to a potential target for treatment and prevention. Read MoreApr 5, 2018
-
Structure of a stem cell niche
Understanding the specialized environment where stem cells reside is important for developing stem-cell based regenerative therapies. Read MoreFeb 28, 2018
-
A target to heal tiny lungs
The protein beta-catenin may be a good target for therapies to treat lung disease that is a common complication of preterm birth. Read MoreFeb 23, 2017
-
Colorectal cancer clues
Although cancers arising from different areas of the large intestine are heterogeneous, they appear to use similar important tumorigenic pathways. Read MoreJan 19, 2017
-
Wound-healing scaffolds
The elasticity of a scaffold used for healing skin wounds is a key factor in promoting regeneration versus scarring. Read MoreJan 27, 2016
-
Healing without scarring
Drugs that inhibit the Wnt signaling pathway can regenerate injured skin and may be useful in treating fibromatosis, degenerative joint disease and cancer. Read MoreOct 16, 2015
-
Heart repair factor
A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack. Read MoreSep 17, 2015
-
Therapeutic target for synovial sarcoma
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. Read MoreNov 21, 2013
-
Fishing for new anti-cancer drugs
Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read MoreSep 18, 2013
-
Long live the therapeutic stem cells
Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help. Read MoreMay 17, 2012
-
Colon cancer’s cellular crossroads
New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease. Read MoreMar 16, 2012
-
Studies pinpoint new anti-cancer drug target
Vanderbilt researchers have discovered a new molecular participant in the Wnt signaling pathway, which plays important roles in cell growth, development and cancer. Read MoreFeb 23, 2012
-
Stem cells take heart
Signaling pathway discoveries suggest ways to induce stem cells to become cardiac muscle cells, which could be useful for regenerating damaged heart muscle. Read MoreFeb 20, 2012